RSS

chronic heart failure

Pharmacosmos’ initiates first hard endpoint randomised controlled trial looking at the effect of intravenous (IV) iron in chronic heart failure (CHF) more

News

The European Commission (EC) has approved Novartis’ Entresto (sacubitril/valsartan) for the treatment of adult patients with symptomatic chronic heart failure with reduced ejection fraction (HFrEF) more

News